Benign recurrent intrahepatic cholestasis progressing to progressive familial intrahepatic cholestasis: Low GGT cholestasis is a clinical continuum

Journal of Hepatology

Volumn 36, Issue 3, 2002, Pages 439-443

  Van Ooteghem, Nancy A M ^a   Klomp, Leo W J ^a   Van Berge Henegouwen, Gerard P ^a   Houwen, Roderick H J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Autosomal recessive; Benign recurrent intrahepatic cholestasis; Cholestasis; Progression; Progressive familial intrahepatic cholestasis

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE;

ADOLESCENT; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; LIVER FIBROSIS; MALE; PRIORITY JOURNAL; RECURRENT DISEASE;

ADOLESCENT; ADULT; BIOPSY; CHOLESTASIS, INTRAHEPATIC; DISEASE PROGRESSION; FAMILY HEALTH; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; MALE; RECURRENCE;

EID: 0036186424     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00299-9     Document Type: Article

References (44)

1. Benign recurrent intrahepatic obstructive cholestasis
2. Benign recurrent intrahepatic cholestasis. A report of 26 cases
3. Benign recurrent intrahepatic cholestasis: A long-term follow-up study of two patients
4. Benign recurrent cholestasis with normal gamma-gluamyl-transpeptidase activity
5. Familial benign recurrent intrahepatic cholestasis. Interrelation with intrahepatic cholestasis of pregnancy and from oral contraceptives?
6. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis
7. Recurrent familial intrahepatic cholestasis in the Faeroe Islands. Phenotypic heterogeneity but genetic homogeneity
8. Characterization of multiple different mutations in FIC1 associated with hereditary cholestasis
9. Benign recurrent intrahepatic cholestasis (BRIC): Evidence of genetic interval between D18S69 and D18S64
10. Autosomal dominant benign recurrent intrahepatic cholestasis (BRIC) unlinked to 18q21 and 2q24
11. Byler's disease: Fatal familial intrahepatic cholestasis in an Amish kindred
12. Genetic and morphological findings in progressive familial intrahepatic cholestasis (Byler disease (PFIC-1) and Byler syndrome): Evidence for heterogeneity
13. Identification of a locus for progressive familial intrahepatic cholestasis PFIC-2 on chromosome 2q24
14. Progressive familial intrahepatic cholestasis: A personal perspective
15. Clinical and biochemical findings in progressive familial intrahepatic cholestasis
16. Normal serum g-glutamyl-transpeptidase activity identifies groups of infants with idiopathic cholestasis with poor prognosis
17. Diagnostic value of serum g-glutamyl transpeptidase activity in liver disease in children
18. Progressive familial cholestatic cirrhosis and bile acid metabolism
19. Progressive idiopathic cholestasis presenting with profuse watery diarrhoea and recurrent infections (Byler's disease)
20. Byler disease, fatal familial intrahepatic cholestasis in an Amish kindred
21. Progressive intrahepatic cholestasis (Byler's disease): Case report
22. Clinical presentation of metabolic liver disease
23. Fatal familial intrahepatic cholestasis (Byler disease)
24. Byler's disease: Fatal intrahepatic cholestasis
25. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis
26. Fine resolution mapping by haplotype evaluation: The examples of PFIC and BRIC
27. Genome screening by genetic association: Mapping of the gene for benign recurrent intrahepatic cholestasis
28. Familial intrahepatic cholestatic syndromes
29. Progressive intrahepatic cholestasis of infancy and childhood. A clinicopathological study of a patient surviving to the age of 18 years
30. Progressive familial intrahepatic cholestasis
31. Benign recurrent intrahepatic cholestasis-25 years of follow-up
32. Benign familial recurrent cholestasis
33. Benign recurrent intrahepatic cholestasis: Studies of bilirubin kinetics, bile acids, and cholangiography
34. Morphological and biochemical studies of benign recurrent cholestasis
35. Benign recurrent intrahepatic cholestasis with response to cholestyramine
36. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis
37. Correspondence: Treatment of patients with benign recurrent intrahepatic cholestasis
38. Benign recurrent intrahepatic cholestasis: Improvement of pruritis and shortening of the symptomatic phase with rifampicin therapy. A case report
39. Use of rifampicin for severe pruritis in children with chronic cholestasis
40. Unexpected clinical remission of cholestasis after rifampicin therapy in patients with normal or slightly increased levels of gamma-glutamyl transpeptidase
41. An essential role for nuclear receptor SXR/PXR in detoxification of bile acids
42. Treatment of progressive familial intrahepatic cholestasis: Liver transplantation or partial external biliary diversion
43. Selective surgical management of progressive familial intrahepatic cholestasis (Byler's disease)
44. Ileal exclusion for Byler's disease: An alternative surgical approach with promising early results for pruritis